Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome

被引:10
|
作者
Khajuria, Bhavik [1 ]
Khajuria, Mansi [2 ]
Agrawal, Yashwant [3 ]
机构
[1] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
关键词
posterior reversible encephalopathy syndrome; PRES; mycophenolate; mycophenolic acid;
D O I
10.1097/MJT.0000000000000270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A 29-year-old woman presented with diffuse anasarca and shortness of breath. Workup revealed a creatinine of 3.3 and a glomerular filtration rate of 17. The patient was also found to be pancytopenic with evidence of hemolytic anemia. A renal biopsy showed evidence of stage IV lupus nephritis with rapidly progressive glomerulonephritis. Her lupus was further classified as ANA negative and anti-dsDNA positive. Mycophenolate and triweekly hemodialysis were started along with a steroid burst of methylprednisolone 1 g for 3 days followed by prednisone 60 mg daily. Four days after discharge, the patient represented with a witnessed 3-minute seizure involving bowel incontinence, altered mental status, and tongue biting. She was given 2 mg intravenous lorazepam and loaded with 1000 mg levetiracetam for seizure prophylaxis. Magnetic resonance imaging of the head revealed bilateral posterior hemispheric subcortical edema, and the diagnosis of posterior reversible encephalopathy syndrome was made. Mycophenolate was immediately discontinued and replaced with cyclophosphamide. Strict blood pressure control below 140/ 90 mm Hg was maintained initially with intravenous nicardipine drip and then transitioned to oral nifedipine, clonidine, losartan, and minoxidil. A repeat head magnetic resonance imaging 8 days later showed resolved subcortical edema consistent with the patient's improved mental status. No permanent neurologic sequelae were recorded as a result of this hospital episode.
引用
收藏
页码:E1072 / E1073
页数:2
相关论文
共 50 条
  • [21] Posterior Reversible Encephalopathy Syndrome
    Sundin, Courtney Stanley
    Johnson, Michelle Laurane
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2018, 43 (02) : 77 - 82
  • [22] Posterior reversible encephalopathy syndrome
    Aria, Robert
    Pisinski, Leszek
    PEDIATRIC RADIOLOGY, 2010, 40 : 171 - 171
  • [23] Posterior Reversible Encephalopathy Syndrome
    Alexandra N. Gewirtz
    Virginia Gao
    Sarah C. Parauda
    Matthew S. Robbins
    Current Pain and Headache Reports, 2021, 25
  • [24] POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
    Raje, Vinayak
    Barve, Pandurang
    Patil, Manisha
    Patil, Devdutta
    Chotai, Trishant
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (96): : 7094 - 7095
  • [25] Posterior reversible encephalopathy syndrome
    Robert Aria
    Leszek Pisinski
    Pediatric Radiology, 2010, 40 : 171 - 171
  • [26] Posterior Reversible Encephalopathy Syndrome
    Gewirtz, Alexandra N.
    Gao, Virginia
    Parauda, Sarah C.
    Robbins, Matthew S.
    CURRENT PAIN AND HEADACHE REPORTS, 2021, 25 (03)
  • [27] Posterior reversible encephalopathy syndrome
    Naqi, Rohana
    Azeemuddin, Muhammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (07) : 657 - 660
  • [28] Posterior reversible encephalopathy syndrome
    Rai, Balaj
    Black, Robert M.
    Gilvaz, Vinit
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (03) : 131 - 132
  • [29] Posterior Reversible Encephalopathy Syndrome
    Lewis, Brian J.
    O'Brien, William T., Sr.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2015, 115 (06): : 401 - 401
  • [30] Posterior reversible encephalopathy syndrome
    Stojanoski, Z.
    Genadieva-Stavrik, S.
    Pivkova, A.
    Karadzova-Stojanoska, A.
    Cevreska, L.
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S331 - S331